LUXE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
LuxExperience BV (LUXE) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company's revenue and net income have shown significant YoY improvement, the recent downgrade by JPMorgan, coupled with the lack of positive trading signals and neutral sentiment from hedge funds and insiders, suggests that the stock may not present an optimal entry point currently. The technical indicators are neutral to slightly bullish, but the lack of strong positive catalysts and recent negative analyst sentiment make it prudent to hold off on buying at this time.
The MACD histogram is positive at 0.045, indicating slight bullish momentum, but it is contracting. RSI is neutral at 52.741, showing no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 9.269, and resistance is at 10.991. The pre-market price of $9.61 is near the support level, suggesting limited immediate upside.
Net income and EPS also improved YoY, indicating better financial performance. Technical indicators show slight bullish momentum.
JPMorgan downgraded the stock to Neutral from Overweight with a reduced price target of $10 (down from $14), citing a correction in the company's Q2 earnings. Gross margin dropped by 7.09% YoY. No recent news or significant trading trends from hedge funds or insiders.
In Q2 2026, revenue increased by 190.12% YoY to $646.92M. Net income improved by 58.58% YoY to -$7.436M, and EPS increased by 80% YoY to -$0.09. However, gross margin declined to 46.42%, down 7.09% YoY.
Analyst sentiment has turned negative recently. JPMorgan downgraded the stock to Neutral from Overweight on February 17, 2026, with a reduced price target of $10 (down from $14), citing a correction in the company's Q2 earnings. Previously, on February 12, 2026, JPMorgan had upgraded the stock to Overweight with a price target of $14, citing attractive risk/reward. This reversal indicates uncertainty in the stock's outlook.
